InvestorsHub Logo
Followers 2
Posts 71
Boards Moderated 0
Alias Born 04/01/2021

Re: None

Tuesday, 02/28/2023 10:29:23 PM

Tuesday, February 28, 2023 10:29:23 PM

Post# of 233278
lenacapivir same efficacy/safety broader impact better delivery for MDR-HIV
more than 80% patients undetectable viral load same as leron
minor safety events, very similar to leron - I HAVE LOOKED AT THEIR SAFETY RESULTS SIDE BY SIDE MORE THAN ONCE. you have not.
leronlimab treats ONLY R5 TROPIC
lenacapivir treats BOTH R5 AND R4 TROPIC.
leronlimab is WEEKLY. was only trialed and approval sought for weekly subq.
lenacapivir is LONG ACTING just 2x annual injection....
leronlimab subq ONLY.
lenacapivir subq OR ORAL administration.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News